Jo Anne Zujewski

23 papers receiving 1.3k citations

Hit Papers

Trastuzumab Plus Adjuvant Chemotherapy for Human Epiderma...20142026201820222014200400600

Peers

Jo Anne Zujewski
Comparison fields: 5 of 87
  • Oncology 1.1k
  • Cancer Research 461
  • Radiology, Nuclear Medicine and Imaging 380
  • Pulmonary and Respiratory Medicine 233
  • Molecular Biology 216
Replace Vernon Harvey with:
Vernon Harvey New Zealand
Miguel Ángel Seguí Spain
Maysa Abu‐Khalaf United States
Hamdy A. Azim Egypt
Mohammad Jahanzeb United States
Jennifer Eng‐Wong United States
Aafke H. Honkoop Netherlands
Stella Dolci Belgium
Chantal Bernard-Marty Belgium
Encarna Adrover Spain
Jo Anne Zujewski relative to Vernon Harvey New Zealand Vernon Harvey's profile →
Citations per field
00.5×1.6×
Vernon Harvey · 1×
Citations per year

Countries citing papers authored by Jo Anne Zujewski

Since Specialization
Citations

This map shows the geographic impact of Jo Anne Zujewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Anne Zujewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Anne Zujewski more than expected).

Fields of papers citing papers by Jo Anne Zujewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Anne Zujewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Anne Zujewski. The network helps show where Jo Anne Zujewski may publish in the future.

Co-authorship network of co-authors of Jo Anne Zujewski

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Anne Zujewski. A scholar is included among the top collaborators of Jo Anne Zujewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Anne Zujewski. Jo Anne Zujewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 5
3 13
4 36
5 5
6 16
7 4
8 76
9 75
10 145
11
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831breakdown →
671
12 101
13 21
14 2
15 12
16 50
17 20
18 7
19
Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
17
20 26

About Jo Anne Zujewski

Jo Anne Zujewski is a scholar working on Oncology, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (8 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (461 citations) and Radiology, Nuclear Medicine and Imaging (380 citations). Jo Anne Zujewski has collaborated with scholars based in United States, Canada and Peru. Frequent co-authors include Edith A. Perez, Julie R. Gralow, Priya Rastogi, Nancy E. Davidson, Vera J. Suman, Charles E. Geyer, E. Mamounas, George W. Sledge, Sandra M. Swain and Norman Wolmark. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026